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Papillomaviruses (PV) are small DNA viruses that induce a wide variety of skin 
and mucous membrane hyperplastic lesions.  They are considered  important 
carcinogens in humans and some high-risk PVs are directly responsible for the 
development of cervical cancers in women [1]. On the other hand, the role of 
PVs in the development of cutaneous squamous cell carcinoma (SCC) is not as 
definite [2]. There is however emerging epidemiological evidence to suggest 
that PV might play an important role in skin cancerogenesis, especially in 
epidermodysplasia (EV) associated-one.  Evidence also suggests that 
ultraviolet (UV) radiation contributes to the cancerization of  some PV-
associated skin cancers [3]. Some animals models support the causative role of 
PV in the induction of skin SCC: A few decades ago, it was demonstrated that 
cottontail rabbit PV (CRPV) are able to induce skin cancers in rabbit [4].  Others 
studies have also established that attenuated life canine oral PV (COPV) 
vaccine induce SCC in Beagles [5]. Additionally, canine and feline can be 
affected by skin conditions that share some similarities with human EV and 
cancerization has been reported in some patients.   
Epidermodysplasia verruciformis (EV) is a rare human genodermatosis 
characterized by multiple flat warts caused by so-called EV associated PV [6]. A 
major clinical complication of EV is the development of squamous cell 
carcinoma (SCC) which is reported in 30 to 50 % of affected people [7]. A 
similar condition is observed in immunocompromised people. Additionally, EV-
like diseases have been described in the dog and cat [8, 9].  
Canine pigmented viral plaques 
A few years ago Nagata described cases of canine viral pigmented plaques and 
suggested that the condition could be the counterpart of human EV[8]. Fourteen 
cases of this condition have now been reported. Affected dogs usually present 
pigmented macules or slightly hyperkeratotic plaques. Carcinomatous 
transformation (In situ and invasive carcinomas) has been frequently reported in 
affected dogs (6 out of 14 cases). 
Feline viral plaques 
Feline viral plaques in older or immunosuppressed cats bear also similarities 
with human EV or canine pigmented viral plaques [9]. Dysplasia or atypia is not 
present but feline viral plaques often coexist in the same animal with bowenoid 
in situ carcinomas. As PV antigens have been uncovered in both lesions on 
same animals, feline viral plaques could be regarded as precursory lesions of 
bowenoid in situ carcinomas (BISC) [10, 11].Positive immunohistochemistry in 
BISC lesions supports a causative role of PV in the development of the lesions 
[12]. 
Skin SCC in dogs 
A few years ago, Bregman and coworkers reported that attenuated life COPV 
vaccine induced skin SCC in 12 out of 500 treated beagles [5]. Several other 
studies carried out using PCR and/or immunohistochemistry concluded that 5 to 
30% of canine SCC harbour PV antigens or nucleic acids [13] Goldschmidt 
detected additionally a novel virus, namely CPV2, in numerous warts and SCC 
of several immuno-compromised Beagles [14]. 
Skin SCC in cats 
Two different studies have demonstrated the presence PV DNA in feline BISC 
and invasive SCC  [15]. One of these studies also suggested that the positive 
samples were infected by PV of great genetic diversity.  One of this virus has 
been additionally recently described [10]. IHC studies have confirmed the 
causal association between virus infection and development of the disease [12] 
PV-induced cell transformation 
Three early PV genes code for the transforming proteins E5, E6 and E7 but not 
all PVs are able to immortalize and transform epithelial cells. Further, 
substantial differences exist in the transforming properties of oncoproteins. 
E5 proteins are small polypeptides with transforming properties. They are the 
major oncoprotein of bovine PV [16]. They induce transformation by enzymatic 
functions, such as activation of several kinases [16]. The open reading frame 
coding for E5 is often deleted in cervical carcinomas in women, indicating that 
this gene does not play an essential role in maintaining the oncogenic 
phenotype in such cancers [17]. The role of E5 in the development of skin 
cancer in humans, dogs and cats is unknown. 
As they play a major role in the development of cervical cancer in women, 
transforming and immortalizing properties of E6 and E7 have been extensively 
studied. The development of such cancer has been linked to persistent 
infections with high-risk HPV and is generally preceded by a lengthy latency 
period [18]. As low-risk HPV genome usually remains episomic, genomic 
integration is one of the key-events of the carcinogenesis induced by high-risk 
HPV[19]. After integration, E6 and E7 expression is maintained but regulatory 
E2 is deleted. The absence of E2 expression provides a growth advantage to 
affected cells [19]. E7 protein interacts with retinoblastoma tumor suppressor 
protein (pRb) and related pocket proteins such as p107 or p130. These proteins 
regulate the activities of transcription factors ( E2F family) that control the cell 
cycle. Additionally, E7 alters cyclin expression (p21 CIP1, p27 KIP1). All in all, E7 
contributes to creating and maintaining a replication competent cellular milieu 
[18, 19].  
On the other hand, the E6 of high-risk mucosal HPV bind the p53 tumor 
suppressor protein as part of a complex with the ubiquitin ligase, E6AP, leading 
to the rapid turnover of p53 [20]. As p53 is a potent inhibitor of cell growth, 
arresting the cell cycle at several points, and under some circumstances, 
activating the apoptotic machinery, its destruction is a major event in the 
transformation and immortalization [21].  
Additionally, E6 and E7 induce cell immortalization through activation of 
telomerase activity and genomic instability through induction of centrosome 
abnormalities [19].  
Interestingly, the E6 of cutaneous HPV does not bind p53 and does not 
promote its degradation [22]. Furthermore, p53 is very often mutated in human 
skin cancers and these mutations are characterized by a specific signature 
attributed to ultraviolet radiation [23]. E6, in turn, targets bak for degradation 
and inhibits UVR-induced apoptosis [22]. These findings emphasize that 
cutaneous HPV-E6 contribution to skin cancerization is markedly different from 
that of mucosal high-risk HPVs.  
The association of HPV and genital cancer is now well established with many 
lines of evidence supporting the causative relationship [2]. On the other hand 
emerging evidence suggests that cutaneous HPVs, including EV-HPV are not 
able to induce keratinocyte immortalization [22]. Cooperation between UV light 
and HPV is probably mandatory for skin oncogenesis. 
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